Mitogen-activated protein kinase phosphatase-1 is a key regulator of hypoxia-induced vascular endothelial growth factor expression and vessel density in lung

American Journal of Pathology

Volumn 178, Issue 1, 2011, Pages 98-109

  Shields, Kristin M ^a   Panzhinskiy, Evgeniy ^b   Burns, Nana ^a   Zawada, W Michael ^b   Das, Mita ^b  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SMOOTH MUSCLE ACTIN; UO 126; VASCULOTROPIN;

ALTITUDE; ALTITUDE ACCLIMATIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; FIBROBLAST; HYPOBARISM; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG BLOOD VESSEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY EPITHELIUM; SEA LEVEL; THICKNESS;

EID: 79251523863     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.025     Document Type: Article

References (44)

1. Camps M, Nichols A, Arkinstall S: Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 2000, 14:6-16
2. Misra-Press A, Rim CS, Yao H, Roberson MS, Stork PJS: A novel mitogen-activated protein kinase phosphatase. Structure, expression and regulation. J Biol Chem 1995, 270:14587-14596
3. Zakkar M, Chaudhury H, Sandvik G, Enesa K, Luong LA, Cuhlmann S, Mason JC, Krams R, Clark AR, Haskard DO, Evans PC: Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ Res 2008, 103:726-732
4. Seta KA, Kim R, Kim HW, Millhorn DE, Beitner-Johnson D: Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis. J Biol Chem 2001, 276:44405-44412
5. Carmeliet P: Angiogenesis in health and disease. Nat Med 2003, 9:653-660
6. Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995, 95:1798-1807
7. Christou H, Yoshida A, Arthur V, Morita T, Kourembanas S: Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1998, 18:768-776 (Pubitemid 128358423)
8. Marti HH, Risau W: Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA1998, 95:15809-15814
9. Kinney CM, Chandrasekharan UM, Mavrakis L, DiCorleto PE: VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration. Am J Physiol Cell Physiol 2008, 294:C241-C250
10. Bellou S, Hink MA, Bagli E, Panopoulou E, Bastiaend PIH, Murphy C, Fotsis T: VEGF auto-regulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells. Am J Physiol Cell Physiol 2009, 297:C1477-C1489
11. Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA, Bravo R: Disruption of the erp/MKP-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 1996, 13:925-931
12. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T: Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 2006, 176:1899-1907
13. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, Baliga RS, Meng X, Smith CV, Bauer JA, Chang CH, Liu Y: MAP kinase phosphatase-1 controls innate immune response and suppresses endotoxic shock. J Exp Med 2006, 203:131-140
14. Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, Choi CS, Neufer PD, Shulman GI, Kim JK, Bennett AM: Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 2006, 4:61-73
15. Carison J, Cui W, Zhang Q, Xu X, Mercan F, Bennett AM, Vignery A: Role of MKP-1 in osteoclasts and bone homeostasis. Am J Pathol 2009, 175:1564-1573
16. Jin Y, Calvert TJ, Chen B, Chicoine LG, Joshi M, Bauer JA, Liu Y, Nelin LD: Mice deficient in MKP-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia. Am J Physiol Heart Circ Physiol 2010, 298:H1518-H1528
17. Nagaoka T, Gebb SA, Karoor V, Homma N, Morris KG, McMurtry IF, Oka M: Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. J Appl Physiol 2006, 100:996-1002
18. Homma N, Nagaoka T, Morio Y, Ota H, Gebb SA, Karoor V, McMurtry IF, Oka M: Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation. J Cardiovasc Pharmacol 2007, 50:697-702
19. Thomas M, Docx C, Holmes AM, Beach S, Duggan N, England K, Leblanc C, Lebret C, Schindler F, Raza F, Walker C, Crosby A, Davies RJ, Morrell NW, Budd DC: Activin-Like Kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline. Am J Pathol 2009, 174:380-389
20. Dempsey EC, Wick MJ, Karoor V, Barr EJ, Tallman DW, Wehling CA, Walchak SJ, Laudi S, Le M, Oka M, Majka S, Cool CD, Fagan KA, Klemm DJ, Hersh LB, Gerard NP, Gerard C, Miller YE: Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia. Am J Pathol 2009, 174:782-796
21. Liu W, Liang Q, Balzar S, Wenzel S, Gorska M, Alam R: Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. J Allergy Clin Immunol 2008, 121:893-902.e2
22. Gesslein B, Håkansson G, Carpio R, Gustafsson L, Perez MT, Malmsjö M: Mitogen-activated protein kinases in the porcine retinal arteries and neuroretina following retinal ischemia-reperfusion. Mol Vis 2010, 16:392-407
23. hi B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy. J Immunol 2010, 184:6142-6150
24. Khan SJ, Pham S, Wei Y, Mateo D, St-Pierre M, Fletcher TM, Vazquez-Padron RI: Stress-induced senescence exaggerates postinjury neointimal formation in the old vasculature. Am J Physiol Heart Circ Physiol 2010, 298:H66-H74
25. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, Gatter KC, Harris AL: DEC1 (STRA13) protein expression relates to hypoxia-inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol 2003, 200:222-228 (Pubitemid 36748031)
26. Das M, Burns N, Wilson SJ, Zawada WM, Stenmark KR: Hypoxia exposure induces the emergence of fibroblasts lacking replication repressor signals of PKCzeta in the pulmonary artery adventitia. Cardiovasc Res 2008, 78:440-448
27. Morrell NW, Atochina EN, Morris KG, Danilov SM, Stenmark KR: Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension [Erratum appeared in J Clin Invest 1996, 97:271]. J Clin Invest 1995, 96:1823-1833
28. Long L, MacLean MR, Jeffery TK, Morecroft I, Yang X, Rudarakanchana N, Southwood M, James V, Trembath RC, Morrell NW: Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 2006, 98:818-827 (Pubitemid 43755266)
29. Crosby A, Jones FM, Southwood M, Stewart S, Schermuly R, Butrous G, Dunne DW, Morrell NW: Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. Am J Respir Crit Care Med 2010, 181:279-288
30. Das M, Bouchey DM, Moore MJ, Hopkins DC, Nemenoff RA, Stenmark KR: Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G-protein-mediated activation of mitogen-activated protein kinases. J Biol Chem 2001, 276:15631-15640
31. Short MD, Fox SM, Lam CF, Stenmark KR, Das M: Protein kinase Czeta attenuates hypoxia-induced proliferation of fibroblasts by regulating MAP kinase phosphatase-1 expression. Mol Biol Cell 2006, 17:1995-2008
32. Laderoute KR, Mendonca HL, Calaoagan JM, Knapp AM, Giaccia AJ, Stork PJ: Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity. J Biol Chem 1999, 274:12890-12897 (Pubitemid 129518066)
33. Liu Y, Gorospe M, Yang C, Holbrook NJ: Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1 dependent gene activation. J Biol Chem 1995, 270:8377-8380
34. Keyse SM, Emslie EA: Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 1992, 359:644-647
35. Kassel O, Sancono A, Krätzschmar J, Kreft B, Stassen M, Cato AC: Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001, 20:7108-7116
36. Wong HR, Dunsmore KE, Page K, Shanley TP: Heat shock-mediated regulation of MKP-1. Am J Physiol Cell Physiol 2005, 289:C1152-C1158
37. Chi H, Flavell RA: Acetylation of MKP-1 and the control of inflammation. Sci Signal 2008, 41:pe44
38. Boutros T, Chevet E, Metrakos P: Mitogen-activated protein (MAP) kinases/MAP kinase phosphatase regulation: roles in cell growth, death and cancer. Pharmacol Rev 2008, 60:261-310
39. McMullen ME, Bryant PW, Glembotski CC, Vincent PA, Pumiglia KM: Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J Biol Chem 2005, 280:20995-21003
40. Baumer S, Keller L, Holtman A, Funke R, August B, Gamp A, Wolburg H, Wolburg-Buchholz K, Deutsch U, Vestweber D: Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 2006, 107:4754-4762
41. Dominguez MG, Hughes VC, Pan L, Simmons M, Daly C, Anderson K, Noguera-Troise I, Murphy AJ, Valenzuela DM, Davis S, Thurston G, Yancopoulos GD, Gale NW: Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci USA 2007, 104:3243-3248
42. Howell K, Ooi H, Preston R, McLoughlin P: Structural basis of hypoxic pulmonary hypertension: the modifying effect of chronic hypercapnia. Exp Physiol 2003, 89:66-72
43. Sakao S, Taraseviciene-Stewart L, Wood K, Cool CD, Voelkel NF: Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth. Am J Physiol Lung Cell Mol Physiol 2006, 291:L362-L368
44. Voelkel NF, Hoeper M, Maloney J, Tuder RM: Vascular endothelial growth factor in pulmonary hypertension. Ann N Y Acad Sci 1996, 796:186-193 (Pubitemid 26405429)